This program was developed as a help in establishing pharmaceutical equivalence by use of FDA f2 coefficient. It was designed to help with f2 computation in cases when intra- and inter-batch variability is large, namely RSD>10%. The use of statistical bootstrap technique allows to implement confidence interval (CI) into the f2 coefficients resulting in overcoming of their major drawback in the original metrics. The algorithm provides possible “worst case scenario” of f2 values, thus supporting claim about pharmaceutical equivalence. The target users are researchers from industry and academia dealing with pharmaceutical equivalence problem.
The software is Open Source. It was developed in Lazarus environment, therefore source code is available in ObjectPascal.

Features

  • automatic computation of f1 and f2 based on the individual drug dissolution profiles
  • bootstrapping used for estimation of f1/f2 distribution
  • full report of the whole computational process
  • graphical representation of the profiles

Project Samples

Project Activity

See All Activity >

License

GNU General Public License version 3.0 (GPLv3)

Follow PhEq_bootstrap

PhEq_bootstrap Web Site

You Might Also Like
Finance Automation that puts you in charge Icon
Finance Automation that puts you in charge

Tipalti delivers smart payables that elevate modern business.

Our robust pre-built connectors and our no-code, drag-and-drop interface makes it easy and fast to automatically sync vendors, invoices, and invoice payment data between Tipalti and your ERP or accounting software.
Rate This Project
Login To Rate This Project

User Reviews

Be the first to post a review of PhEq_bootstrap!

Additional Project Details

Operating Systems

Linux, Windows

Languages

English

Intended Audience

Healthcare Industry, Science/Research, Education

User Interface

X Window System (X11), Win32 (MS Windows), Qt

Programming Language

Lazarus

Related Categories

Lazarus Simulation Software, Lazarus Medical Software, Lazarus Statistics Software

Registered

2012-09-23